_id

69105930ccc777a4e85d5736

Ticker

DAWN

Name

Day One Biopharmaceuticals Inc

Exchange

NASDAQ

Address

1800 Sierra Point Parkway, Brisbane, CA, United States, 94005

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://dayonebio.com

Description

Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.

Last Close

8.42

Volume

930796

Current Price

8.36

Change

-0.7125890736342102

Last Updated

2025-11-29T12:07:52.725Z

Image

data:image/webp;base64,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

Ipo Date

2021-05-27T00:00:00.000Z

Market Cap

974390528

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.6777

Sentiment Sources

7

Rating

4.375

Target Price

22.25

Strong Buy

4

Buy

3

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

39795000

Cost Of Revenue

4480000

Gross Profit

35315000

Operating Expenses

59566000

Operating Income

-24251000

Interest Expense

-

Pretax Income

-19726000

Net Income

-19726000

Eps

-0.19080817457197174

Dividends Per Share

-

Shares Outstanding

102675502

Income Tax Expense

-

EBITDA

-18787000

Operating Margin

-60.93981655986933

Total Other Income Expense Net

4525000

Cash

43277000

Short Term Investments

408303000

Receivables

16697000

Inventories

7061000

Total Current Assets

489971000

Property Plant Equipment

4677000

Total Assets

513780000

Payables

5778000

Short Term Debt

161000

Long Term Debt

-

Total Liabilities

62912000

Equity

450868000

Depreciation

885000

Change In Working Capital

7547000

Cash From Operations

-5805000

Capital Expenditures

0

Cash From Investing

13460000

Cash From Financing

0

Net Change In Cash

7655000

PE

-

PB

1.9168976139357858

ROE

-4.375116442062865

ROA

-3.839386507843824

FCF

-5805000

Fcf Percent

-0.14587259705993216

Piotroski FScore

1

Health Score

35

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

3.5

Growth Investing Score

2

Momentum Investing Score

2.5

Net Net Investing Score

2.5

Quality Investing Score

3

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

39795000

Quarters > 0 > income Statement > cost Of Revenue

4480000

Quarters > 0 > income Statement > gross Profit

35315000

Quarters > 0 > income Statement > operating Expenses

59566000

Quarters > 0 > income Statement > operating Income

-24251000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-19726000

Quarters > 0 > income Statement > net Income

-19726000

Quarters > 0 > income Statement > eps

-0.19080817457197174

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

103381315

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-18787000

Quarters > 0 > income Statement > operating Margin

-60.93981655986933

Quarters > 0 > income Statement > total Other Income Expense Net

4525000

Quarters > 0 > balance Sheet > cash

43277000

Quarters > 0 > balance Sheet > short Term Investments

408303000

Quarters > 0 > balance Sheet > receivables

16697000

Quarters > 0 > balance Sheet > inventories

7061000

Quarters > 0 > balance Sheet > total Current Assets

489971000

Quarters > 0 > balance Sheet > property Plant Equipment

4677000

Quarters > 0 > balance Sheet > total Assets

513780000

Quarters > 0 > balance Sheet > payables

5778000

Quarters > 0 > balance Sheet > short Term Debt

161000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

62912000

Quarters > 0 > balance Sheet > equity

450868000

Quarters > 0 > cash Flow > net Income

-19726000

Quarters > 0 > cash Flow > depreciation

885000

Quarters > 0 > cash Flow > change In Working Capital

7547000

Quarters > 0 > cash Flow > cash From Operations

-5805000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

13460000

Quarters > 0 > cash Flow > cash From Financing

0

Quarters > 0 > cash Flow > net Change In Cash

7655000

Quarters > 0 > ratios > PE

-0.19080817457197174

Quarters > 0 > ratios > PB

1.9168976139357858

Quarters > 0 > ratios > ROE

-4.375116442062865

Quarters > 0 > ratios > ROA

-3.839386507843824

Quarters > 0 > ratios > FCF

-5805000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.14587259705993216

Quarters > 0 > health Score

35

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

33908000

Quarters > 1 > income Statement > cost Of Revenue

3765000

Quarters > 1 > income Statement > gross Profit

30143000

Quarters > 1 > income Statement > operating Expenses

65117000

Quarters > 1 > income Statement > operating Income

-34974000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-30322000

Quarters > 1 > income Statement > net Income

-30322000

Quarters > 1 > income Statement > eps

-0.2941908303623022

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

103069154

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-29358000

Quarters > 1 > income Statement > operating Margin

-103.14380087295034

Quarters > 1 > income Statement > total Other Income Expense Net

4652000

Quarters > 1 > balance Sheet > cash

35622000

Quarters > 1 > balance Sheet > short Term Investments

417481000

Quarters > 1 > balance Sheet > receivables

19669000

Quarters > 1 > balance Sheet > inventories

6543000

Quarters > 1 > balance Sheet > total Current Assets

494428000

Quarters > 1 > balance Sheet > property Plant Equipment

4816000

Quarters > 1 > balance Sheet > total Assets

519037000

Quarters > 1 > balance Sheet > payables

5090000

Quarters > 1 > balance Sheet > short Term Debt

153000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

58203000

Quarters > 1 > balance Sheet > equity

460834000

Quarters > 1 > cash Flow > net Income

-30322000

Quarters > 1 > cash Flow > depreciation

886000

Quarters > 1 > cash Flow > change In Working Capital

-2265000

Quarters > 1 > cash Flow > cash From Operations

-24806000

Quarters > 1 > cash Flow > capital Expenditures

3497000

Quarters > 1 > cash Flow > cash From Investing

26322000

Quarters > 1 > cash Flow > cash From Financing

748000

Quarters > 1 > cash Flow > net Change In Cash

2264000

Quarters > 1 > ratios > PE

-0.2941908303623022

Quarters > 1 > ratios > PB

1.8697798500978662

Quarters > 1 > ratios > ROE

-6.579809649461628

Quarters > 1 > ratios > ROA

-5.841972730267784

Quarters > 1 > ratios > FCF

-28303000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-0.8346997758641028

Quarters > 1 > health Score

35

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

30761000

Quarters > 2 > income Statement > cost Of Revenue

2884000

Quarters > 2 > income Statement > gross Profit

27877000

Quarters > 2 > income Statement > operating Expenses

68944000

Quarters > 2 > income Statement > operating Income

-41067000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-35996000

Quarters > 2 > income Statement > net Income

-35996000

Quarters > 2 > income Statement > eps

-0.3504624671404927

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

102710000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-35102000

Quarters > 2 > income Statement > operating Margin

-133.5034621761321

Quarters > 2 > income Statement > total Other Income Expense Net

5071000

Quarters > 2 > balance Sheet > cash

33358000

Quarters > 2 > balance Sheet > short Term Investments

439662000

Quarters > 2 > balance Sheet > receivables

18054000

Quarters > 2 > balance Sheet > inventories

3565000

Quarters > 2 > balance Sheet > total Current Assets

508651000

Quarters > 2 > balance Sheet > property Plant Equipment

5085000

Quarters > 2 > balance Sheet > total Assets

534356000

Quarters > 2 > balance Sheet > payables

2540000

Quarters > 2 > balance Sheet > short Term Debt

62000

Quarters > 2 > balance Sheet > long Term Debt

0

Quarters > 2 > balance Sheet > total Liabilities

54844000

Quarters > 2 > balance Sheet > equity

479512000

Quarters > 2 > cash Flow > net Income

-35996000

Quarters > 2 > cash Flow > depreciation

819000

Quarters > 2 > cash Flow > change In Working Capital

-32506000

Quarters > 2 > cash Flow > cash From Operations

-58997000

Quarters > 2 > cash Flow > capital Expenditures

3817000

Quarters > 2 > cash Flow > cash From Investing

-32613000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-91610000

Quarters > 2 > ratios > PE

-0.3504624671404927

Quarters > 2 > ratios > PB

1.790686364470545

Quarters > 2 > ratios > ROE

-7.506798578554864

Quarters > 2 > ratios > ROA

-6.736333081316576

Quarters > 2 > ratios > FCF

-62814000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-2.042001235330451

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

29208000

Quarters > 3 > income Statement > cost Of Revenue

2982000

Quarters > 3 > income Statement > gross Profit

26226000

Quarters > 3 > income Statement > operating Expenses

91558000

Quarters > 3 > income Statement > operating Income

-65331999

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-59240000

Quarters > 3 > income Statement > net Income

-65714000

Quarters > 3 > income Statement > eps

-0.701896208163655

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

93623529

Quarters > 3 > income Statement > income Tax Expense

6474000

Quarters > 3 > income Statement > EBITDA

-58480999

Quarters > 3 > income Statement > operating Margin

-223.67844083812653

Quarters > 3 > income Statement > total Other Income Expense Net

6092000

Quarters > 3 > balance Sheet > cash

124968000

Quarters > 3 > balance Sheet > short Term Investments

406752000

Quarters > 3 > balance Sheet > receivables

13876000

Quarters > 3 > balance Sheet > inventories

3321000

Quarters > 3 > balance Sheet > total Current Assets

562330000

Quarters > 3 > balance Sheet > property Plant Equipment

4707000

Quarters > 3 > balance Sheet > total Assets

582788000

Quarters > 3 > balance Sheet > payables

3262000

Quarters > 3 > balance Sheet > short Term Debt

10000

Quarters > 3 > balance Sheet > long Term Debt

0

Quarters > 3 > balance Sheet > total Liabilities

80037000

Quarters > 3 > balance Sheet > equity

502751000

Quarters > 3 > cash Flow > net Income

-65714000

Quarters > 3 > cash Flow > depreciation

759000

Quarters > 3 > cash Flow > change In Working Capital

26735000

Quarters > 3 > cash Flow > cash From Operations

-30008000

Quarters > 3 > cash Flow > capital Expenditures

1419000

Quarters > 3 > cash Flow > cash From Investing

-269640000

Quarters > 3 > cash Flow > cash From Financing

1851000

Quarters > 3 > cash Flow > net Change In Cash

-297797000

Quarters > 3 > ratios > PE

-0.701896208163655

Quarters > 3 > ratios > PB

1.5568197824370313

Quarters > 3 > ratios > ROE

-13.070883996252618

Quarters > 3 > ratios > ROA

-11.275798403536106

Quarters > 3 > ratios > FCF

-31427000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-1.0759723363462066

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.19080817457197174

Valuation > metrics > PB

1.9168976139357858

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-4.375116442062865

Profitability > metrics > ROA

-4.025952556375786

Profitability > metrics > Net Margin

-0.4956904133685136

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.13953529636168457

Risk > metrics > Interest Coverage

-25.826411075612352

Risk > final Score

-43

Risk > verdict

High

Liquidity > metrics > Current Ratio

82.50058932480215

Liquidity > metrics > Quick Ratio

81.31166863108267

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-85

Prev Risks > 1

-124

Prev Risks > 2

-284

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:23:09.023Z